These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. Circulation; 2014 Jul 01; 130(1):94-125. PubMed ID: 24815500 [No Abstract] [Full Text] [Related]
8. Implantable cardioverter-defibrillator: present and future indications. Block M, Scheld H, Breithardt G. Arch Mal Coeur Vaiss; 1996 Feb 01; 89 Spec No 1():141-7. PubMed ID: 8734176 [Abstract] [Full Text] [Related]
9. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy. Patel C, Yan GX, Kocovic D, Kowey PR. Circ Arrhythm Electrophysiol; 2009 Dec 01; 2(6):705-11; discussion 712. PubMed ID: 20009081 [No Abstract] [Full Text] [Related]
15. [Implantable cardioverter-defibrillator: prevention of sudden cardiac death and impact on survival in patients with malignant ventricular arrhythmias]. Occhetta E, Magnani A, Francalacci G, Perucca A, Sarasso G, Piccinino C, Trevi G. Cardiologia; 1995 Jun 08; 40(6):419-25. PubMed ID: 8640855 [No Abstract] [Full Text] [Related]
19. [Nursing care for automatic implantable defibrillators]. Pépin A, Samuel B, Kihel A. Soins; 2006 Jan 08; (702 Suppl):S3-5. PubMed ID: 16493932 [No Abstract] [Full Text] [Related]